Semaglutide Injectable Product

DRUG10 trials

Conditions

AgingAlcohol AbuseAlcohol AddictionAlcohol DependenceAlcohol Use DisorderAtrial FibrillationChronic Heart FailureDiabetes Mellitus, Type 2

Phase 2

Effects of Semaglutide in HIV-Associated Lipohypertrophy

Active, not recruitingNCT04019197

Case Western Reserve UniversityHIV/AIDS, Lipohypertrophy, Obesity

Start: 2019-05-16End: 2026-02-28Updated: 2026-02-27

Semaglutide vs Metformin in Polycystic Ovary Syndrome (PCOS)

Not yet recruitingNCT05646199

University of HullPolycystic Ovary Syndrome

Start: 2025-03-01End: 2025-12-30Target: 60Updated: 2024-05-10

Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity?

CompletedNCT05895643

Psychiatric Centre RigshospitaletAlcohol Abuse, Alcohol Addiction, Alcohol Dependence +1

Start: 2023-06-13End: 2025-07-31Updated: 2025-08-05

Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart Failure

RecruitingNCT06423599

Jens D Hove, MD,PHDChronic Heart Failure, Heart Failure With Reduced Ejection Fraction, Obesity +1

Start: 2024-05-17End: 2026-12-30Target: 100Updated: 2024-05-24

A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonist

CompletedNCT06500429

Neurogastrx, Inc.Healthy, Overweight and Obesity

Start: 2024-06-24End: 2024-09-13Updated: 2025-09-04

Phase 3

Semaglutide for the Reduction of Arrhythmia Burden in Overweight AF Patients

WithdrawnNCT04885634

Axel BrandesAtrial Fibrillation, Overweight and Obesity

Start: 2022-10-31End: 2024-11-30Updated: 2023-11-03

Phase 4

Effect of GLP1 Receptor Agonists on Physical Function, Body Composition, and Markers of Aging in Older Adults

CompletedNCT05786521

The University of Texas Health Science Center at San AntonioAging, Diabetes Mellitus, Type 2, Overweight and Obesity +1

Start: 2023-04-01End: 2024-05-20Updated: 2025-05-04

Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes

RecruitingNCT06706284

Marzieh SalehiSpinal Cord Injuries, Type 2 Diabetes

Start: 2025-04-11End: 2029-01-01Target: 50Updated: 2025-11-26

Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity

RecruitingNCT07136714

Nordsjaellands HospitalMajor Depressive Disorder

Start: 2025-09-11End: 2027-09-01Target: 116Updated: 2026-02-06

Unknown Phase

Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV

RecruitingNCT04174755

University College DublinHIV-1-infection, Obesity

Start: 2022-06-22End: 2026-01-31Target: 80Updated: 2024-12-16

2025-11-27

Effects of Semaglutide on Cognitive Function in People with HIV: A Randomized Controlled Trial.

2025-10-16

Blood phosphatidylethanol measurements indicate <scp>GLP</scp>‐1 receptor stimulation causes delayed decreases in alcohol consumption

Alcohol Clinical and Experimental Research2025-03-235 citations

The Effects of Semaglutide on Inflammation and Immune Activation in HIV-associated Lipohypertrophy

Open Forum Infectious Diseases2025-03-204 citations

Does semaglutide reduce alcohol intake in Danish patients with alcohol use disorder and comorbid obesity? Trial protocol of a randomised, double-blinded, placebo-controlled clinical trial (the SEMALCO trial)

BMJ Open2025-01-018 citations

Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 receptor agonist in opioid use disorder

Addiction Science & Clinical Practice2024-07-276 citations

Effect of Semaglutide on Physical Function, Body Composition, and Biomarkers of Aging in Older Adults With Overweight and Insulin Resistance: Protocol for an Open-Labeled Randomized Controlled Trial

JMIR Research Protocols2024-07-119 citations

Once-weekly semaglutide in people with HIV-associated lipohypertrophy: a randomised, double-blind, placebo-controlled phase 2b single-centre clinical trial.

2024-07-0123 citations

An enhanced participant information leaflet and multimedia intervention to improve the quality of informed consent to a randomised clinical trial enrolling people living with HIV and obesity: a protocol for a Study Within A Trial (SWAT).

2022-01-173 citations